| Drugs by Condition |  |
Head and Neck Cancer Medications
Drugs associated with Head and Neck Cancer
The following drugs and medications are in some way related to, or used in the treatment of Head and Neck Cancer. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
||
|---|---|---|---|---|
Taxotere (Pro, More...) generic name: docetaxel class: mitotic inhibitors | 0 review(s) | Not rated - Be the first | ||
| Erbitux (More...)generic name: cetuximab class: antineoplastic monoclonal antibodies, EGFR inhibitors, tyrosine kinase inhibitors | 1 review(s) |  | 7.0 | |
| Trexall (More...)generic name: methotrexate class: antimetabolites, antipsoriatics, antirheumatics | 0 review(s) | Not rated - Be the first | ||
See also...
Head and Neck Cancer Medications in the Pipeline
Advexin (p53 tumor suppressor therapy)
- September 2, 2008 - Introgen Receives Notice Advexin U.S. BLA Not Sufficiently Complete to File
- June 30, 2008 - Introgen Submits Advexin Regulatory Applications in the U.S. and Europe
- December 20, 2007 - Introgen Plans to Expand Biomarker Database in Phase 3 Trials and File BLA and MAA for Advexin in Advanced Head and Neck Cancer in First Half of 2008
Latest Head and Neck Cancer Blog Post
BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
WOBURN, Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that updated survival data from its Phase II study in metastatic melanoma...
View all Head and Neck Cancer blog posts.
